PAPER Zhou Y, Liyanage PY, Devadoss D, Rios Guevara LR, Cheng L, Graham RM, Chand HS, Al-Youbi AO, Bashammakh AS, El-Shahawi MS, Leblanc RM
SEARCH RESULTS
16174 RESULTS
PAPER Martín-Belmonte A, Aguado C, Alfaro-Ruíz R, Moreno-Martínez AE, de la Ossa L, Martínez-Hernández J, Buisson A, Früh S, Bettler B, Shigemoto R, Fukazawa Y, Luján R
Reduction in the neuronal surface of post and presynaptic GABAB receptors in the hippocampus in a mouse model of Alzheimer's disease.
Brain Pathol. 2020 May;30(3):554-575. Epub 2019 Dec 12 PubMed: 31729777PAPER Lang M, Rosselli M, Greig MT, Torres VL, Vélez-Uribe I, Arruda F, Barker WW, Garcia P, Loewenstein DA, Curiel RE, Duara R
Depression and the Diagnosis of MCI in a Culturally Diverse Sample in the United States.
Arch Clin Neuropsychol. 2019 Nov 12; PubMed: 31729523PAPER Nikolenko VN, Oganesyan MV, Vovkogon AD, Nikitina AT, Sozonova EA, Kudryashova VA, Rizaeva NA, Cabezas R, Avila-Rodriguez M, Neganova ME, Mikhaleva LM, Bachurin SO, Somasundaram SG, Kirkland CE, Tarasov VV, Aliev G
Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases.
Curr Neuropharmacol. 2019 Nov 12; PubMed: 31729299PAPER Soukup O, Korabecny J
Editorial: Multi Target- Directed Ligands in the Treatment of Alzheimer's Disease.
Curr Alzheimer Res. 2019;16(9):771. PubMed: 31729288PAPER Li X, Guan J, Sun T, Yang J, Yu H, Yao J, Wang Z
Circadian learning and memory changes in Aβ1-42 induced Alzheimer's mice.
Metab Brain Dis. 2020 Mar;35(3):463-471. Epub 2019 Nov 14 PubMed: 31728887PAPER Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS
Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.
Neurotherapeutics. 2020 Jan;17(1):252-268. PubMed: 31728850PAPER Yuyama K, Takahashi K, Usuki S, Mikami D, Sun H, Hanamatsu H, Furukawa J, Mukai K, Igarashi Y
Plant sphingolipids promote extracellular vesicle release and alleviate amyloid-β pathologies in a mouse model of Alzheimer's disease.
Sci Rep. 2019 Nov 14;9(1):16827. PubMed: 31727994PAPER Zhu H, Tang Z, Cheng H, Wu Y, Fan Y
Multi-atlas label fusion with random local binary pattern features: Application to hippocampus segmentation.
Sci Rep. 2019 Nov 14;9(1):16839. PubMed: 31727982PAPER Kim DK, Han D, Park J, Choi H, Park JC, Cha MY, Woo J, Byun MS, Lee DY, Kim Y, Mook-Jung I
Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
Exp Mol Med. 2019 Nov 15;51(11):1-17. PubMed: 31727875PAPER Jethwa KD, Dhillon P, Meng D, Auer DP, Alzheimer’s Disease Neuroimaging Initiative
Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?
AJNR Am J Neuroradiol. 2019 Dec;40(12):2039-2044. Epub 2019 Nov 14 PubMed: 31727757PAPER Benwell CS, Davila-Pérez P, Fried PJ, Jones RN, Travison TG, Santarnecchi E, Pascual-Leone A, Shafi MM
EEG spectral power abnormalities and their relationship with cognitive dysfunction in patients with Alzheimer's disease and type 2 diabetes.
Neurobiol Aging. 2020 Jan;85:83-95. Epub 2019 Oct 14 PubMed: 31727363PAPER Karanfilian L, Tosto MG, Malki K
The role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models.
Neurobiol Aging. 2020 Feb;86:39-53. Epub 2019 Sep 23 PubMed: 31727362PAPER Deardorff WJ, Grossberg GT
Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia.
Handb Clin Neurol. 2019;165:5-32. PubMed: 31727229PAPER Ben-Nejma IR, Keliris AJ, Daans J, Ponsaerts P, Verhoye M, Van der Linden A, Keliris GA
Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis.
Acta Neuropathol Commun. 2019 Nov 14;7(1):180. PubMed: 31727182Current Filters
- Date Range : Nov 2018 to Nov 2019 x